Alnylam Pharmaceuticals
ALNY
#652
Rank
C$53.37 B
Marketcap
C$399.78
Share price
-0.03%
Change (1 day)
6.20%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company